AI Biomed PredictionsPYPD – PolyPid Nears NDA Completion With Regulatory Repricing Potential ScanScor Admin / May 2, 2026
AI Biomed PredictionsOSTX – OSTX Faces Its Defining FDA Pathway Test This Month ScanScor Admin / May 2, 2026
AI Biomed PredictionsACXP – Microcap ACXP hinges on proof ibezapolstat development is truly starting ScanScor Admin / May 2, 2026
AI Biomed PredictionsNRSN – May regulatory clarity could decide NeuroSense’s next ALS breakout ScanScor Admin / May 2, 2026
AI Biomed PredictionsTRAW – MHRA decision could reawaken Traws’ deeply discounted antiviral story ScanScor Admin / April 30, 2026
AI Biomed PredictionsRNAZ – Phase 2a clearance may decide RNAZ’s next sharp move ScanScor Admin / April 30, 2026
AI Biomed PredictionsINAB – Microcap IN8bio could reprice sharply on fresh survival data ScanScor Admin / April 30, 2026
AI Biomed PredictionsHIND – Phase 3 clarity could awaken this forgotten microcap biotech ScanScor Admin / April 30, 2026
AI Biomed PredictionsGTBP – GTB-5550 clinical launch may spark GTBP’s next rebound ScanScor Admin / April 30, 2026
AI Biomed PredictionsCELZ – Final ADAPT Data Could Reprice Tiny-Float CELZ Sharply ScanScor Admin / April 30, 2026
